Natco Pharma share news, announcements and annual reports
NSE: NATCOPHARMBSE: 524816Pharmaceuticals & BiotechnologySmall Cap
Natco Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Dec 1995 on NSE
Last close ₹782.40down ₹5.15 (0.65%)BSE ₹782.50
Share price at the NSE close on 30 Oct 2026. Previous close ₹787.55.
30 Oct: open ₹792.05, high ₹800.90, low ₹779.50
52-week range of traded prices to 30 Oct 2026
₹773.60Low, 22 Oct 2026₹1,226.80High, 12 May 2026
- Next results date: the board meets on 13 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,348 Cr380th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.58%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,21,54744.0% delivered
Natco Pharma board meetings
128 filed, newest first. Page 3 of 3.
Jan 2012
30 Jan · Board meeting
To consider among other things, the unaudited financial Results for the Quarter ended December 31, 2011, to consider Interim Dividend , if any, for the financial year 2011-2012 and related matters etc.
Oct 2011
28 Oct · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended September 30, 2011 and related matters etc.
Aug 2011
16 Aug · Board meeting
Board of Director of the Company at their meeting held on August 12, 2011 had considered and approved the following: (1) Constitution of a committee of Directors to finalise the issue price, tenor and other terms and conditions for the issue of Foreign Currency Convertible Bonds. (2) Action of the Compensation committee of Directors in granting 2,36,551 only Options to the Employees of the Company at Rs.10/- each, which will be vested to the employees on or before October 31, 2012. Each Option when vested and exercised, will result in a right to apply for and obtain allotment of 1(one) equity share of Rs.10/- per share.1 Aug · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended June 30, 2011, convening of Annual General Meeting and related matters etc.
May 2011
18 May · Board meeting
To consider among other things, approval of the annual accounts and consolidated financial results of the Company for the year ended on March 31, 2011 and related matters.
Feb 2011
2 Feb · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended December 31, 2010, and to consider Interim Dividend, if any, for the financial year 2010-11 and related matters etc.
Nov 2010
15 Nov · Board meeting
Board of Directors of the Company, at their meeting held on November 15, 2010, considered the following: (1) Compensation Committee granted 6,00,000 options of Rs.10/- each to the employees under Employee Stock Option Scheme NATSOP2010; (2) The Company is planning to raise funds to the tune of Rs.100 crores through appropriate capital offering. For seeking shareholders approval Board decided to convene Extra-ordinary General Meeting (EGM) of the Company to be held on December 15, 2010.2 Nov · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended September 30, 2010 and related matters etc.
Aug 2010
3 Aug · Board meeting
Board of Directors at their meeting held on July 31, 2010 have taken on record the following : (1) To convene Annual General Meeting (AGM) of the Company to be held on September 30, 2010; (2) Issue of shares to the employees of the Company under Employee Stock Option Scheme (ESOS).
Jul 2010
21 Jul · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended June 30, 2010, convening of Annual General Meeting and related matters etc.
May 2010
26 May · Board meeting
To consider among other things, consideration of audited financial results for the year ended March 31, 2010 and related matters.
Apr 2010
20 Apr · Board meeting
Board of Directors of the Company had its meeting held on April 19, 2010 resolved to convene an Extraordinary General Meeting of the members of the Company to be held on May 18, 2010 for consideration of Increase in Authorised Share Capital, Amendment to the Memorandum and Articles of Association and for filling the casual vacancy in the office of the Auditor.
Jan 2010
13 Jan · Board meeting
Board Meeting is convened to consider among other things, consideration of declaration of Interim Dividend, if any, for the Financial Year 2009-2010, the un-audited financial results (Provisional) for the quarter ended December 31, 2009 and related matters.
Oct 2009
20 Oct · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended September 30, 2009.
Jul 2009
30 Jul · Board meeting
Board of Directors have taken on record the following at their meeting held on July 30, 2009 : 1) Dr. A.K.S. Bhujanga Rao inducted as an Additional Director of the Board and designated him as President (R&D and Technical). 2) Board authorised Chairman and Managing Director of the Company to fix up the date of Annual General Meeting, Book Closure dates and venue etc.20 Jul · Board meeting
To consider among other things, the Unaudited financial Results for the quarter ended June 30, 2009 and convening of Annual General Meeting and related matters etc.
Jun 2009
30 Jun · Board meeting
Board of Directors of the Company at their meeting held on June 30, 2009 considered and approved the Audited Results for the quarter ended March, 2009. Further:- 1)Mrs. Durgadevi Nannapaneni, Whole Time Director of the Company resigned as a Director and to the position of the Whole Time Director w.e.f. July 1, 2009 due to her personal reasons. 2) Company allotted 1,07,125 shares under ESOP 2004 out of which 12,500 shares were allotted to Dr. Jasti S. Rao, an independent Non-promoter Director and 2,500 shares to Mr. P.Bhaskara Narayana, Director & Chief Financial Officer.18 Jun · Board meeting
To consider among other things the Audit Results for the Financial year ended March 31, 2009 and related matters.
May 2009
14 May · Board meeting
To consider among other things, consideration of declaration of Interim Dividend, if any, for the Financial Year 2008-2009 and related matters.
Jan 2009
15 Jan · Board meeting
To consider among other things, the Un-audited financial results (Provisional) for the quarter ended December 31, 2008.
Oct 2008
20 Oct · Board meeting
To consider among other things, the Un-audited financial results (Provisional) for the quarter ended September 30, 2008.
Jul 2008
21 Jul · Board meeting
To consider among other things, the Unaudited financial Results for the quarter ended June 30, 2008 and convening of Annual General Meeting and related matters etc.
Jun 2008
17 Jun · Board meeting
To consider among other things, the Audited Results for the financial year ended March 31, 2008, audited accounts for the year 2007-08 and related matters.
Jan 2008
21 Jan · Board meeting
To consider among other things, the unaudited financial results (Provisional) for the quarter ended December 31, 2007 and related matters.
Oct 2007
16 Oct · Board meeting
To consider among other things, the unaudited financial results (Provisional) for the quarter ended September 30, 2007, consideration of declaration of Interim Dividend, if any, for the financial year 2007-2008 and related matters.
Jul 2007
16 Jul · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended June 30, 2007 and related matters.
Jun 2007
20 Jun · Board meeting
To consider among other things, the Audited Results for the financial year ended March 31, 2007, audited accounts for the year 2006-07 and related matters.
Jan 2007
17 Jan · Board meeting
To consider among other things, the unaudited financial results (Provisional) for the quarter ended December 31, 2006 and related matters.